SEC Form 4/A · accession 0001209191-15-051242
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Gregory S Weishar
Officer — Chief Executive Officer · Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 8, 2015 · 9:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1,F2 | Jun 2, 2015 | S | 22,855 | $32.97 | D | 660,170 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales were inadvertently omitted from the reporting person's Form 4 filed on 06/04/2015 due to clerical error.
- F2Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $32.90 and $33.021, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.